Michael Millward

Professor, MB BS W.Aust., MA Melb., FRACP

  • The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth

    Australia

  • 7091 Citations
  • 36 h-Index
20042021
If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

  • Cancer
  • Clinical trials

Fingerprint Dive into the research topics where Michael Millward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 26 Similar Profiles
Melanoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Circulating Neoplastic Cells Medicine & Life Sciences
Mutation Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

2 Citations (Scopus)

First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Antitumor Activity

Gan, H. K., Millward, M., Hua, Y., Qi, C., Sai, Y., Su, W., Wang, J., Zhang, L., Frigault, M. M., Morgan, S., Yang, L. & Lickliter, J. D., 15 Aug 2019, In : Clinical Cancer Research. 25, 16, p. 4924-4932 9 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel

Gray, E. S., Witkowski, T., Pereira, M., Calapre, L., Herron, K., Irwin, D., Chapman, B., Khattak, M. A., Raleigh, J., Hatzimihalis, A., Cebon, J., Sandhu, S., McArthur, G. A., Millward, M., Ziman, M., Dobrovic, A. & Wong, S. Q., May 2019, In : JOURNAL OF MOLECULAR DIAGNOSTICS. 21, 3, p. 418-426 9 p.

Research output: Contribution to journalArticle

Immunomagnetic-enriched subpopulations of melanoma circulating tumour cells (CTCs) exhibit distinct transcriptome profiles

Aya-Bonilla, C., Gray, E. S., Manikandan, J., Freeman, J. B., Zaenker, P., Reid, A. L., Khattak, M. A., Frank, M. H., Millward, M. & Ziman, M., 1 Feb 2019, In : Cancers. 11, 2, 157.

Research output: Contribution to journalArticle

Open Access
Circulating Neoplastic Cells
Transcriptome
Melanoma
Gene Expression
Epithelial-Mesenchymal Transition
2 Citations (Scopus)

Incidence, features and management of radionecrosis in melanoma patients treated with cerebral radiotherapy and anti-PD-1 antibodies

da Silva, I. P., Glitza, I. C., Haydu, L. E., Johnpulle, R., Banks, P. D., Grass, G. D., Goldinger, S. M. A., Smith, J. L., Everett, A. S., Koelblinger, P., Roberts-Thomson, R., Millward, M., Atkinson, V. G., Guminski, A., Kapoor, R., Conry, R. M., Carlino, M. S., Wang, W., Shackleton, M. J., Eroglu, Z. & 5 othersLo, S., Hong, A. M., Long, G. V., Johnson, D. B. & Menzies, A. M., Jul 2019, In : PIGMENT CELL & MELANOMA RESEARCH. 32, 4, p. 553-563 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Is the blood an alternative for programmed cell death ligand 1 assessment in non-small cell lung cancer?

Acheampong, E., Spencer, I., Lin, W., Ziman, M., Millward, M. & Gray, E., 1 Jul 2019, In : Cancers. 11, 7, 920.

Research output: Contribution to journalReview article

Open Access
Non-Small Cell Lung Carcinoma
Cell Death
Ligands
Circulating Neoplastic Cells
CD274 Antigen

Projects 2004 2021